Jason M. Broderick

The vaccines did not result in reductions in semen volume, sperm concentration, sperm motility, and total motile sperm count.

Array BioPharma Inc released its financial results for the third quarter of fiscal 2010, reporting $18.4 million in total revenue for the period but a net loss of $15.2 million, or $0.30 per share.

A struggle with cancer is often referred to as a battle. Now, a study reveals patients with cancer and caregivers even experience a condition common to soldiers, post-traumatic stress syndrome.

The American Society of Clinical Oncology (ASCO) updated its 2003 recommendations for genetic testing to keep pace with exponential progress in genetic science.

The United States spent $2.3 trillion ($7681 per person) on healthcare in 2008, with costs continuing to outstrip available resources.

The FDA Center for Devices and Radiological Health, in collaboration with the National Cancer Institute Enterprise Vocabulary Service, launched a Website (http://tinyurl.com/mlptu7) updating its coding system for reporting adverse events related to medical devices.

THIS YEAR HAS ALREADY SEEN quite a bit of activity on the medical marijuana front. In January, New Jersey became the 14th state in the nation to legalize marijuana use for certain chronic illnesses.

Researchers at the University of Oklahoma (OU) have been investigating focused microwave thermotherapy (FMT), a microwave treatment capable of destroying large cancer tumors in patients with breast cancer.

When our home state of New Jersey became the 14th state in the nation to legalize medical marijuana, OBTN decided to take a closer look at the herbal remedy. With help from oncologists on our advisory board, we sought to filter through the smoke and examine the ealities of medical marijuana.

Chemotherapy recipients have long complained of decreased mental function during and after treatment, yet the medical community has only recently acknowledged the reality of chemo brain, the term for chemotherapy's degenerative effect on normal cognitive function.

Scientists at Fred Hutchinson Cancer Research Center in Seattle, Washington, successfully tested a mechanism that increases the number of progenitor cells extracted from a unit of human umbilical cord blood. The laboratory method potentially solves the 1- to 2-month delay in myeloid engraftment after cord blood transplantation (CBT).

In a phase III study of 1052 patients, nanoparticle albumin-bound (nab) paclitaxel (Abraxane)produced significant improvement in the overall response rate compared with standard paclitaxel in the first-line treatment of patients with advanced non–small cell lung cancer (NSCLC).

In a new report, published in the March issue of the Journal of Clinical Oncology, investigators led by Harold J. Burstein, MD, PhD, associate professor of medicine, Harvard Medical School, Cambridge, Massachusetts, say monotherapy with neratinib, an investigational tyrosine kinase inhibitor, demonstrated substantial clinical activity in patients with HER2-positive breast cancer with manageable toxicity.

Early-stage diagnosis gives patients their best chance against lung cancer. The rush to adopt lung cancer screening seems premature, however, because no randomized trials have definitively demonstrated that it improves survival outcomes. The National Lung Screening Trial (NLST), sponsored by the National Cancer Institute, aims to supply this data, with final results expected in ~1 year.

Provenge (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant prostate cancer (also referred to as hormone-refractory), has become the first FDA-approved therapeutic vaccine for cancer. The highly anticipated approval follows nearly 2 decades of research and development that included a controversial rejection of the vaccine by the FDA in 2007.

Three hot gadgets for Oncologists.

A US district court invalidated 7 of 23 of Myriad Genetics, Inc's patents on the BRCA1 and BRCA2 genes, which confer an increased risk of developing breast, ovarian, and prostate cancers. If upheld, the decision by Judge Robert W. Sweet would threaten existing patents on thousands of genes and curtail the rights of an individual or organization to patent a gene.

When our home state of New Jersey became the 14th state in the nation to legalize medical marijuana, OBTN decided to take a closer look at the herbal remedy. With help from oncologists on our advisory board, we sought to filter through the smoke and examine the realities of medical marijuana.